News & Updates

Intense ADT tied to positive pathologic responses in prostate cancer

23 Jun 2021

Intense neoadjuvant hormone therapy in high-risk localized prostate cancer is associated with favourable pathologic responses (tumour <5 mm) in nearly one of five patients, a phase II study has shown. In addition, pathologic responses are comparable between treatment groups.

Intense ADT tied to positive pathologic responses in prostate cancer

23 Jun 2021

Potentially inappropriate medications in CKD linked to dim outcomes

23 Jun 2021

Chronic kidney disease (CKD) patients prescribed potentially inappropriate medications (PIMs) risk falling, being hospitalized, and dying, with the greatest risk occurring among those who have more than one PIM prescription, as shown in a study.

Potentially inappropriate medications in CKD linked to dim outcomes

23 Jun 2021

Dupilumab may reduce exacerbations in paediatric uncontrolled asthma

22 Jun 2021 by

Children with uncontrolled moderate-to-severe asthma may benefit from treatment with dupilumab which reduced exacerbations and improved lung function, according to results of the phase III VOYAGE study presented at ATS 2021.

Dupilumab may reduce exacerbations in paediatric uncontrolled asthma

22 Jun 2021

Finasteride lowers bladder cancer risk in men, but not in Blacks

22 Jun 2021

Use of finasteride reduces the incidence of bladder cancer in men, as corroborated by findings of a recent study. However, this reduction is observed only in White and Hispanic but not Black men.

Finasteride lowers bladder cancer risk in men, but not in Blacks

22 Jun 2021

Product Highlight - MYCOZOLE

22 Jun 2021

MYCOZOLE/MYCOZOLE IV – Fluconazole 150 mg capsule and Fluconazole 2 mg/mL solution for infusion

Product Highlight - MYCOZOLE

22 Jun 2021

Product Highlight - Tationil 600

22 Jun 2021

Tationil 600^® – Glutathione 600 mg lyophilized powder for injection

Product Highlight - Tationil 600

22 Jun 2021

Iron pill safely fills iron stores in CKD patients with anaemia over long term

21 Jun 2021 by

In patients with chronic kidney disease (CKD) and iron-deficiency anaemia, the orally administered ferric maltol appears to yield meaningful and sustained increases in haemoglobin and iron indices, with a low rate of treatment discontinuation due to adverse events, according to the results of the phase III AEGIS-CKD trial and open-label extension.

Iron pill safely fills iron stores in CKD patients with anaemia over long term

21 Jun 2021

Topiramate works for secondary prevention of cyclic vomiting syndrome with red flags

21 Jun 2021

Topiramate appears to be an effective second-line prophylactic medication against moderate-to-severe cyclic vomiting syndrome in adults but at the cost of side effects, a study has shown.

Topiramate works for secondary prevention of cyclic vomiting syndrome with red flags

21 Jun 2021

Pharmacist involvement in paediatric oncology clinic lowers adverse events, readmission

20 Jun 2021

The inclusion of a clinical oncology pharmacist into an ambulatory care pharmacy in paediatric haematology–oncology and transplant clinic results in reduced adverse events and fewer readmission into the hospital, a study has shown.

Pharmacist involvement in paediatric oncology clinic lowers adverse events, readmission

20 Jun 2021

Certain rheuma therapies tied to poorer COVID-19 outcomes, impaired vaccine response

19 Jun 2021 by

Certain therapies used for rheumatic diseases, including rituximab, are associated with worse outcomes for COVID-19 and reduced immune response after COVID-19 vaccination in patients with rheumatic diseases, according to two studies presented at the virtual EULAR 2021 Congress.

Certain rheuma therapies tied to poorer COVID-19 outcomes, impaired vaccine response

19 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Intense ADT tied to positive pathologic responses in prostate cancer

Intense ADT tied to positive pathologic responses in prostate cancer

Potentially inappropriate medications in CKD linked to dim outcomes

Potentially inappropriate medications in CKD linked to dim outcomes

Dupilumab may reduce exacerbations in paediatric uncontrolled asthma

Dupilumab may reduce exacerbations in paediatric uncontrolled asthma

Finasteride lowers bladder cancer risk in men, but not in Blacks

Finasteride lowers bladder cancer risk in men, but not in Blacks

Product Highlight - MYCOZOLE

Product Highlight - MYCOZOLE

Product Highlight - Tationil 600

Product Highlight - Tationil 600

Iron pill safely fills iron stores in CKD patients with anaemia over long term

Iron pill safely fills iron stores in CKD patients with anaemia over long term

Topiramate works for secondary prevention of cyclic vomiting syndrome with red flags

Topiramate works for secondary prevention of cyclic vomiting syndrome with red flags

Pharmacist involvement in paediatric oncology clinic lowers adverse events, readmission

Pharmacist involvement in paediatric oncology clinic lowers adverse events, readmission

Certain rheuma therapies tied to poorer COVID-19 outcomes, impaired vaccine response

Certain rheuma therapies tied to poorer COVID-19 outcomes, impaired vaccine response